Hypertension guidelines and their limitations – the impact of physicians’ compliance as evaluated by guideline awareness
- 1 November 2001
- journal article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 19 (11) , 2079-2086
- https://doi.org/10.1097/00004872-200111000-00020
Abstract
The initial step of an optimal therapeutic strategy for patients with arterial hypertension is the recognition and acceptance of new recommendations by the physicians themselves. This guideline awareness of the physicians has never been evaluated in detail. The awareness of content of current recommendations in hypertension diagnosis, treatment and treatment control was therefore assessed in primary care physicians using a questionnaire. The guidelines of the German Hypertension Society were used as the reference standard. A total of 24 899 German physicians, including all internists, all cardiologists and 22% of general practitioners were contacted in a nationwide survey. The number of answers in agreement with the guideline was used as a measure of guideline awareness. Adequate awareness of content of guideline recommendations was defined as the correct answer to five out of eight questions; the correct answers had to include the appropriate definition of hypertension. The analysis was based on 11 547 returned questionnaires (47.1%). An adequate guideline awareness was found in 23.7% of the total study population, especially in 37.1% of cardiologists, in 25.6% of internists and in 18.8% of general practitioners. While the guideline awareness was significantly influenced by the duration of private practice, regional and municipal factors had only minor influence on the results. The impact of hypertension guidelines on actual medical knowledge is modest. Thus, the information strategies about current treatment guidelines must be improved and tailored to the needs of physicians in clinical practice to ultimately improve patient care.Keywords
This publication has 18 references indexed in Scilit:
- Implications of a health lifestyle and medication analysis for improving hypertension control.Archives of internal medicine (1960), 2000
- Guidelines for management of hypertension: report of the third working party of the British Hypertension SocietyJournal of Human Hypertension, 1999
- Antihypertensive treatment and the prevention of dementiaJournal Of Hypertension, 1999
- Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trialThe Lancet, 1998
- Systolic blood pressure, isolated systolic hypertension and risk of coronary heart disease, strokes, cardiovascular disease and all-cause mortality in the middle-aged populationJournal Of Hypertension, 1998
- Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research GroupJAMA, 1997
- Issues in Patient Compliance: The Search for Therapeutic SufficiencyCardiology, 1992
- Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)The Lancet, 1991
- Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research GroupJAMA, 1991
- Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. A cooperative studyPublished by American Medical Association (AMA) ,1977